Public Administration

Synthetic data to improve planning, governance, and public decision-making.

Aindo helps public authorities, regional healthcare organizations, and government agencies use data responsibly to improve planning, policy, and population health.

Whether you are planning healthcare capacity, assessing policy impact, or coordinating across institutions, Aindo turns fragmented data into actionable insights.

How synthetic data supports decision-making

Secure data sharing

Generate secure datasets for policy analysis, health research, and impact evaluation.

Analysis-ready datasets

Generate datasets that are safe by design for policy analysis and public health research.

Forecasting & simulation

Support healthcare planning with scenario modeling and predictive analytics.

Faster governance

Reduce data access delays and regulatory bottlenecks.

Built for Europe's advanced healthcare regulations.

Designed for the new European health data framework and certified for data processing in healthcare.

Europrivacy

Europrivacy

Art 42 GDPR

ISO 9001 Quality

ISO 9001

Quality

ISO 27001 Information security

ISO 27001

Information security

Gender Equality

Gender Equality

UNI PDR 125:2022

NIST Cybersecurity Framework

NIST

Cybersecurity & privacy

How to use our synthetic data

  • Population health analytics

  • Capacity planning

  • Policy simulation

  • Cross-regional collaboration

  • Public health surveillance

  • Digital health innovation in public health

From raw data to policy-ready datasets

Talk to our experts
Ingest and harmonize healthcare data

Ingest and harmonize healthcare data

Clinical data are ingested and mapped to a standardized structure.

Generate and validate synthetic cohorts

Generate and validate synthetic cohorts

Synthetic data are generated and validated for utility, bias, and privacy.

Deliver compliant, analysis-ready datasets

Deliver compliant, analysis-ready datasets

Teams receive cohorts ready for analysis, sharing, and iteration.

Synthetic data enable the formulation of clinical hypotheses in real time, allowing rapid exploration of data.

Andrew C. Davis, MD, MPH
Andrew C. Davis, MD, MPHClinical Professor, UChicago Medicine (USA)

Synthetic control arms reduce trial costs and improve patient recruitment by minimizing the need for placebo groups.

Michael H. Tardugno, MD
Michael H. Tardugno, MDExecutive Chairman, Imunon Inc

Synthetic data represent a new informational infrastructure for healthcare systems, enabling better planning, evaluation and governance.

Giorgio Lorenzo Colombo
Giorgio Lorenzo ColomboProfessor of Health Economics, University of Pavia

Synthetic data accelerate researchers' access to health data, facilitating the generation of clinical evidence.

Aldren Gonzales, PhD
Aldren Gonzales, PhDU.S. Dept. of Health and Human Services

Build the future of medical intelligence

Accelerate research and enable safe, compliant clinical AI.